←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Peptide Drug Conjugate
Nahoko Sato-Dahlman
MD, PhD
🏢University of Minnesota🌐USA
Assistant Professor of Pediatrics
20
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Nahoko Sato-Dahlman develops retargeted oncolytic adenoviruses and peptide drug conjugates for pediatric cancer including sarcoma. Her work combines peptide tumor targeting with payload delivery strategies. She is an emerging leader in peptide-directed cancer therapeutics.
Share:
🧪Research Fields 研究领域
tumor targeting peptides
oncolytic adenovirus
peptide drug conjugates
pediatric cancer
retargeting
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Nahoko Sato-Dahlman 的研究动态
Follow Nahoko Sato-Dahlman's research updates
留下邮箱，当我们发布与 Nahoko Sato-Dahlman（University of Minnesota）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment